London, UK
11/05/2024Beyond Basic Exosomes: How “Hybrosome” Technology Is Advancing Regenerative Skin Treatments
At a recent aesthetic medicine congress, Dr. Anna Peca presented an overview of hybrosomes — a next-generation technology that combines two well-known concepts in skin science: exosomes and liposomes.
In simple terms, exosomes are tiny natural “messenger bubbles” that cells use to communicate with each other, carrying instructions that can help skin repair and renew itself. However, as we age, our own cells often don’t have enough energy or raw materials to fully respond to these messages — so exosomes alone can only do so much.
This is where Hybrosomes come in. Instead of relying on exosomes by themselves, Hybrosomes merge exosome signaling proteins with liposomes — protective, nutrient-carrying capsules. The result is a hybrid particle that does two things at once: it delivers the “renewal signal” (like an exosome) while also supplying the actual nutrients and building blocks skin cells need to act on that signal.
Dr. Peca explained that this dual-action approach allows for more predictable and consistent results than traditional exosome-based treatments, because the technology doesn’t just tell skin cells to regenerate — it also gives them the tools to do so. In her talk, she emphasized three key effects observed with hybrosome- based formulations:
• Building stronger, healthier skin resilience over time
• Targeting specific concerns like wrinkles, uneven tone, and loss of firmness
• Creating the right internal environment for the skin to keep renewing itself
Her presentation framed hybrosomes as a bridge between advanced biotechnology and clinical aesthetic practice — offering practitioners a more targeted, science- backed tool for skin rejuvenation.